A possible new role for Helicobacter pylori in the development of ocular adnexal lymphoma†
On the relative safety of intravenous iron formulations
Ocular adnexal lymphoma and Helicobacter pylori gastric infection†
Use of parenteral iron products and serious anaphylactic‐type reactions†‡ §
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia†
Clarithromycin (Biaxin)‐lenalidomide‐low‐dose dexamethasone (BiRd) versus lenalidomide‐low‐dose dexamethasone (Rd) for newly diagnosed myeloma
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells†
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia
Modified non‐overt DIC diagnostic criteria predict the early phase of overt‐DIC†
Invasive fungal disease in patients treated for newly diagnosed acute leukemia†‡
Heparin‐induced thrombocytopenia
Neutrophil dysplasia demonstrated on Sudan black B staining†
Coagulopathy in a patient with nephrotic syndrome†‡
Resolution of massive pleural effusion due to lymphoma with intrapleural interleukin‐2†
Necrosis following skull base irradiation and stem cell transplant for multiple myeloma†
Effective management of accelerated phase myelofibrosis with low‐dose splenic radiotherapy†
Alteration of cohesin genes in myeloid diseases†
Clinical significance of clonality and Epstein‐Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis†
Acute life‐threatening cardiovascular toxicity with umbilical cord blood infusion
Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag†
Screening coagulation testing using the APTT
Hepatosplenic T cell lymphoma responsive to 2′‐deoxycoformycin therapy†
Acute leukemia presenting with extramedullary diseases and completely normal hemogram
Hemoglobin disorders in the developing world
Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen†
August crossword answers